LivingGLP1
Study S001205

CLOSED LOOP SYSTEM IN TYPE 1 DIABETES MANAGEMENT COMPARISON WITH PRAMLINTIDE Vs EXENATIDE

Registration

Registration
NCT01269008
Acronym
Closedloop
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE1
Masking
NONE
Status
COMPLETED
Enrollment
13
Start
2010-12
Primary completion
2013-01
Lead sponsor
Albert Einstein College of Medicine
Conditions
Type 1 Diabetes
Interventions
DEVICE:Medtronic ePID 2.0
Results posted
FALSE

Registered primary outcomes

  • Better meal and post meal sugars on the closed loop device using the study medications. [18 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.